Healthcare IT Market Projected To Be Worth $644.9 Billion By 2030: Grand View Research Inc.

 

Healthcare IT Market Growth & Trends

The global healthcare IT market size is expected to reach USD 166.0 billion by 2028 and is expected to grow at a CAGR of 10.7% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand and adoption of preventive care along with increasing funding for various mobile health startups is boosting the market growth. In addition, growing network coverage and rising improvements in network infrastructure are further driving the market.

The Covid-19 pandemic has also boosted the demand for online or virtual medical consultancy, globally, owing to the developments and innovations in internet-based technologies, the growing prevalence of chronic diseases, and increasing adoption and positive consumer behavior pertaining to newer technologies in healthcare. According to a 2020 survey conducted by Deloitte, the pandemic propelled the adoption of virtual health. For instance, the percent of consumers or respondents utilizing virtual visits increased from 15% in 2019 to 19% in the initial months of 2020 and a sudden spike of around 28% was witnessed in April 2020. Thus, such instances are likely to support market growth in the coming years.

In 2020, the Electronic Health Records (EHRs) application segment dominated the global market accounting for a revenue share of over 40%. This growth was attributed to the surge in demand for streamlining EHR, EHR-integrated tools, and advancements in information technology. Furthermore, the segment is estimated to retain its leading position throughout the forecast years due to factors, such as growing awareness and adoption in healthcare facilities, strategic initiatives by key players in the healthcare IT space, and an increasing number of initiatives supporting its implementation. For instance, in 2020, Cerner announced the launch of its first virtual EHR implementation in Macon Community Hospital, Tennessee.

Request a free sample copy or view report summary: Healthcare IT Market Report

Healthcare IT Market Report Highlights

• The market is anticipated to witness significant growth over the forecast period owing to the rising demand and adoption of preventive care
• North America dominated the global market in 2020 and will grow further at a steady CAGR from 2021 to 2028
• This growth is credited to the rising adoption and implementation of IT services and solutions by healthcare providers for delivering enhanced patient care at lower expenses
• Moreover, the increasing number of hospitals, advanced research centers, and universities along with the presence of key manufacturing hubs in North America will support the market growth in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-it-market

Healthcare IT Market Segmentation

Grand View Research has segmented the global healthcare IT market on the basis of application and region:

Healthcare IT Application Outlook (Revenue, USD Million, 2016 - 2028)

• Electronic Health Records (EHRs)
• Computerized Provider Order Entry Systems (CPOE)
• Electronic Prescribing Systems
• PACS
• Laboratory Information Systems
• Clinical Information Systems
• Tele-healthcare

Healthcare IT Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Healthcare IT Market

• Philips Healthcare
• Agfa Healthcare
• Hewlett-Packard Enterprise
• Carestream Health
• GE Healthcare
• E-MDS, Inc.
• Athenahealth, Inc.
• eClinicalworks
• McKesson Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Industrial Fasteners Market Witness Excellent Revenue Growth During 2024-2030: Grand View Research Inc

 

Industrial Fasteners Market Growth & Trends

The global industrial fasteners market size is expected to reach USD 131.28 billion by 2030, registering a CAGR of 4.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is anticipated to be driven by factors such as the increasing population, significant investments in the construction industry, and rising demand in industries such as aerospace and automotive.

Industrial fasteners are available in two major types: metal and plastic. Metal fasteners dominated the industry; however, the product is expected to witness lower growth as compared to its counterpart owing to the increasing penetration of materials such as plastic in applications such as aerospace and automotive on account of their high corrosion resistance and lightweight characteristics.

The global market is highly competitive owing to the presence of a large number of manufacturers. A major challenge faced by the competitors is the fluctuation of raw material prices; hence, a high degree of backward and forward integration is likely to be observed among the major players. This will further intensify the market rivalry and competition, making it difficult for emerging players to sustain themselves in the market.

The demand for industrial fasteners is directly influenced by the growth of the building and construction industry and product penetration. Asia Pacific is expected to witness the highest growth over the forecast period owing to the rapid expansion and magnitude of the construction industry in countries such as India and China. The growing population and high investments in the construction sector are the key factors driving the construction industry in these countries, which, in turn, is projected to boost industry growth over the forecast period.

Major industrial fastener manufacturing companies are established in North America and Asia Pacific; as a result, the shortage of global supply for industrial fasteners provides a great business opportunity for players in these regions. Asia Pacific is expected to be the preferred market for fastener manufacturers owing to high product demand, coupled with the lower costs associated with raw materials, labor, land, and power.

Request a free sample copy or view report summary: Industrial Fasteners Market Report

Industrial Fasteners Market Report Highlights

• Externally threaded fasteners accounted for the highest revenue share in 2023. High investments in the region's agriculture, construction, and mining sectors are expected to propel the demand for heavy equipment such as material handling, excavation, drilling, hauling, paving, grading, and lifting machinery. This, in turn, is likely to propel the demand during the projected period
• Metal fasteners account for the largest market share of over 90% in 2023. They offer high mechanical strength and impact resistance and are less susceptible to harsh conditions such as high temperature and pressure, which is expected to drive the demand over the forecast period
• Asia Pacific is the fastest-growing region in the world, accounting for more than 44% of the market share in 2023 owing to the growth in the infrastructure sector in the Asia Pacific region. Furthermore, automotive, industrial machinery, and electronic applications will drive the regional market for industrial fasteners
• The automotive segment accounted for the largest revenue share in 2023. High production volumes of automotive vehicles across Asia Pacific have been driving the industry over the past few years. Metal has been dominating the segment over the past few decades. However, the rising popularity of plastic fasteners owing to their lightweight and low cost is expected to drive the industry
• The market is highly competitive and consists of several global and regional players. Opportunities for new players are anticipated as the need for creative and application-specific fastener designs rises. Rising raw material costs and high volume production by established competitors are anticipated to be major obstacles for new entrants.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-aerospace-plastics-market

Industrial Fasteners Market Segmentation

Grand View Research has segmented the industrial fasteners market on the basis of on raw material, product, application, distribution channel, and region:

Industrial Fasteners Raw Material Outlook (Revenue, USD Million; 2018 - 2030)

• Metal Fasteners
• Plastic Fasteners

Industrial Fasteners Product Outlook (Revenue, USD Million; 2018 - 2030)

• Externally Threaded Fasteners
• Internally Threaded Fasteners
• Non-threaded Fasteners
• Aerospace Grade Fasteners

Industrial Fasteners Application Outlook (Revenue, USD Million; 2018 - 2030)

• Automotive
• Aerospace
• Building & Construction
• Industrial Machinery
• Home Appliances
• Lawns And Gardens
• Motors And Pumps
• Furniture
• Plumbing products
• Others

Industrial Fasteners Distribution Channel Outlook (Revenue, USD Million; 2018 - 2030)

• Direct
• Indirect

Industrial Fasteners Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Indonesia
  • Thailand
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa

List of Key Players in the Industrial Fasteners Market

• Arconic Fastening Systems and Rings
• Acument Global Technologies, In
• ATF, Inc.
• Dokka Fasteners A S
• LISI Group - Link Solutions for Industry
• Nippon Industrial Fasteners Company (Nifco)
• Hilti Corporation
• MW Industries, Inc.
• Birmingham Fasteners and Supply, Inc.
• SESCO Industries, Inc.
• Elgin Fasteners Group LLC
• Rockford Fasteners, Inc.
• Slidematic
• Manufacturing Associates, Inc.
• Eastwood Manufacturing
• Brunner Manufacturing CO., Inc.
• Decker Industries Corporation
• Penn Engineering & Manufacturing Corporation
• EJOT
• Illinois Tool Works, Inc.
• Stanley Black & Decker, Inc.
• KOVA Fasteners Pvt. Ltd.
• Standard Fasteners Ltd.
• Precision Castparts Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Aerospace Plastics Market Forecasted to Grow at Steady Pace During 2023-2030: Grand View Research Inc.

 Aerospace Plastics Market Growth & Trends

The global aerospace plastics market size is expected to reach USD 13.89 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.0% from 2023 to 2030. Non-corrosive nature and high-temperature resistance of plastics are expected to bolster market growth over the forecast period.

Aerospace plastics exhibit high strength and heat resistance and properties. It's high modulus of elasticity aids in the production of various aircraft components such as empennage, airframe, and fuselage. In addition, plastics are lightweight nevertheless high-performance alternatives to metals such as steel and aluminum; as a result, the market is expected to grow significantly.

Easy adoption in aircraft designs coupled with high durability and chemical resistance offered by the product is expected to drive market over the forecast period. However, the components manufactured with the use of plastic polymers are hard to inspect for flaws, leading to quality variations and defects resulting in increased incidents of plastic fracture. This leads to high operating repair and maintenance costs are posing a threat to aerospace plastics market growth.

Aerospace plastics provide a high degree of freedom in the designing of complicated components of an aircraft. This has resulted in an increase in the percentage of material utilization in manufacturing military and commercial aircraft significantly over the past couple of decades, which in turn has bolstered the demand for plastics in aerospace applications.

Commercial aircraft manufacturers are entering into supply agreements with plastic resins & composite manufacturers to develop a reliable supply channel for their aircraft components. In November 2020, Boeing awarded a long-term enterprise agreement to Solvay for supplying advanced materials such as adhesives, surfacing films, and thermoplastic and thermoset, composites for aircraft interior section, secondary structures, and primary structures.

Request a free sample copy or view report summary: Aerospace Plastics Market Report

Aerospace Plastics Market Report Highlights

• Cabin interiors dominated the application segment and accounted for more than 30.0% of the overall revenue share in 2022. The growing use of plastics in seat & seating components, cabin dividers, overhead cabins, and other interior components for improving the appearance of the cabin. This is attributed to its flexibility, impact strength, high-temperature resistance, and corrosion resistance similar to metals
• Commercial and freighter aircraft accounted for the majority of the revenue share. The rapid growth in the air passenger traffic has led to the increased production of commercial aircraft, which in turn is expected to bolster the demand for the plastics
• North America accounted for the over 57.3% of the revenue share in 2022. The growing demand for commercial aircraft coupled with the presence of Boeing, a leading manufacturer of aircraft is expected to drive the demand for aerospace polymers in the region
• The market is fragmented wherein the global players adopt various marketing and pricing strategies to gain market share and acquire the business from major aircraft manufacturers such as Airbus, Boeing, and Lockheed Martin
• In November 2021, Solvay collaborated with Switzerland-based OEM 9T Labs AG to produce low-to-medium size aerospace parts. This collaboration aims at producing carbon reinforcedpolyphenylene sulfide, polyamide, and polyetheretherketonecomposite materials for aircraft components
• In April 2019, DuPont opened a new Aerospace Technology Center at its manufacturing site in Ohio. The new Technology Center supports the support present and future aerospace design projects aerospace designs and provide technology advancements related to these designs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-aerospace-plastics-market

Aerospace Plastics Market Segmentation

Grand View Research has segmented the global aerospace plastics market on the basis of plastic type, process, application, end-use, and region:

Aerospace Plastics Plastic Type Outlook (Volume, Tons; Revenue, USD Million, 2019 - 2030)

• Polyetheretherketone (PEEK)
• Polyphenylsulfone (PPSU)
• Polycarbonate (PC)
• Polyetherimide (PEI)
• Polymethyl Methacrylate (PMMA)
• Polyamide (PA)
• PolyPhenyleneSulfide (PPS)
• Polyamide-imide (PAI)
• Polyphenylene Ether (PPE)
• Polyurethane (PU)
• Others

Aerospace Plastics Process Outlook (Volume, Tons; Revenue, USD Million, 2019 - 2030)

• Injection Molding
• Thermoforming
• CNC Machining
• Extrusion
• 3D Printing
• Others

Aerospace Plastics Application Outlook (Volume, Tons; Revenue, USD Million, 2019 - 2030)

• Cabin Interiors
• Structural Components
• Electrical, Electronics, And Control Panel
• Window & Windshields, Doors, And Canopies
• Flooring & Wall Panels

Aerospace Plastics End-Use Outlook (Volume, Tons; Revenue, USD Million, 2019 - 2030)

• Commercial & Freighter Aircraft
• General Aviation
• Military Aircraft
• Rotary Aircraft

Aerospace Plastics Regional Outlook (Volume, Tons; Revenue, USD Million, 2019 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Western Europe
  • Germany
  • UK.
  • France
• Eastern Europe
• China
• Asia
  • India
  • Japan
• Southeast Asia
  • Indonesia
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates

List of Key Players of Aerospace Plastics Market

• Victrex plc
• Ensinger
• SABIC
• Solvay
• BASF SE
• Evonik Industries AG
• Toray Advanced Composites
• Saint Gobain Aerospace
• DuPont
• Celanese Corporation
• Sumitomo Chemical Co., Ltd.
• Covestro AG
• the Mitsubishi Chemical Group of companies
• PPG Industries, Inc.
• Röchling

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Circulating Tumor Cells Market Top Players, Segments, Cost Structure, Demand by 2030| Top Industry Leaders Apocell, Vitatex Inc.

 

Circulating Tumor Cells Market Growth & Trends

The global circulating tumor cells market size is expected to reach USD 27.55 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 13.34% from 2023 to 2030. Many potential applications of circulating tumor cells (CTCs) in pre-diagnosis, pretreatment, and intra- and post-treatment provide lucrative growth opportunities to players involved in the development of CTC enrichment and isolation products. Research organizations are involved in activities, which are aimed at developing CTC-based tests to improve cancer diagnosis in terms of efficiency and speed. Furthermore, the growing demand for personalized medicines and growing research for drug development is anticipated to tailor treatment for individuals at the genetic and molecular levels. For instance, according to the research study conducted by Indiana University School of Medicine in October 2021, the presence of CTC and circulating tumor DNA (ctDNA) in the plasma of women who have received pre-surgery chemotherapy for triple-negative breast cancer is one of the important indicators to predict disease recurrence. Thus, these factors are anticipated to drive the market growth over the forecast period.

Moreover, the rising demand for minimally invasive diagnostic treatments is anticipated to impel funds from key stakeholders in this area. CTC-based liquid biopsy tests lead to limited trauma and allow speedy recovery attributing to its non-invasive nature. Furthermore, it assists in minimally invasive screening of cancer formerly opting for complicated surgical treatments, which include surgical removal of tumors, chemotherapy, and radiotherapy, thus positively impacting the adoption of circulating tumor cells.

The limited applicability of these cells in rare cancers has hampered revenue growth to a certain extent. Circulating tumor cells are not applicable to tumors characterized by EpCAM negativity or low expression, such as neurogenic cancers. For instance, there is negligible evidence for the characterization of circulating tumor cells for sarcoma. Conversely, numerous methods are being studied for the isolation of these cells, which include methods based on epithelial antigen-targeted antibodies, anticipating to overcome these challenges in the coming years.

However, in recent years there has been a push for practical application, largely as a result of a wave of large players centralizing the technology through acquisitions and numerous partnerships with pharmaceutical firms to advance the formation of a value chain and speed up market growth. For instance, in June 2023, to develop a novel test for the detection of tumor cells that metastatic cancers shed into the blood, the University of Washington School of Medicine collaborated with RareCyte, Inc. which is a biotech company headquartered in Seattle. In addition, according to the research, the understanding of the circulating tumor cells in the bloodstream can track the changes in tumor cells, thus optimizing the treatment.

Request a free sample copy or view report summary: Circulating Tumor Cells Market Report

Circulating Tumor Cells Market Report Highlights

• Based on the technology, the CTC detection & enrichment methods dominated the market in 2022 with a revenue share of 65.3%owing to the increased availability of products for CTC enrichment and isolation as well as high usage and product penetration across the globe
• The growing application potential of CTC analysis for investigational research, drug development, and biomarker studies will result in the segment's highest CAGR from 2023 to 2030
• Based on application, the research segment accounted for the largest share in 2022 and is projected to grow at the fastest CAGR during the forecast period. This is attributed to the growing number of research studies for better treatment of cancer
• Based on product, the devices and systems segment dominated the market with a revenue share of 43.0% in 2022 owing to the presence of highly efficient automated systems and high usage of systems for the detection of tumor cells
• The whole blood specimens are the key source of circulating tumor cells. As a result, the segment has accounted for the largest revenue share of 46.5% in 2022. The blood specimen segment is also projected to exhibit a significant growth rate during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-circulating-tumor-cells-market

Circulating Tumor Cells Market Segmentation

Grand View Research has segmented the global circulating tumor cells market based on technology, application, product, specimen, and region:

Circulating Tumor Cells Technology Outlook (USD Million, 2018 - 2030)

• CTC Detection & Enrichment Methods
  • Immunocapture (Label-based)
    • Positive Selection
    • Negative Selection
  • Size-based Separation (Label-free)
    • Membrane-based
    • Microfluidic-based
  • Density-based Separation (Label-free)
  • Combined Methods (Label-free)
• CTC Direct Detection Methods
  • SERS
  • Microscopy
  • Others
• CTC Analysis

Circulating Tumor Cells Application Outlook (USD Million, 2018 - 2030)

• Clinical/Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
• Research
  • Cancer Stem Cell & Tumorogenesis Research
  • Drug/Therapy Development

Circulating Tumor Cells Product Outlook (USD Million, 2018 - 2030)

• Kits & Reagents
• Blood Collection Tubes
• Devices or Systems

Circulating Tumor Cells Specimen Outlook (USD Million, 2018 - 2030)

• Blood
• Bone Marrow
• Other Body Fluids

Circulating Tumor Cells Regional Outlook (USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Circulating Tumor Cells Market

• QIAGEN
• Bio-Techne Corporation
• Precision for Medicine
• AVIVA Biosciences
• BIOCEPT, Inc.
• BioCEP Ltd.
• Fluxion Biosciences, Inc.
• Greiner Bio One International GmbH
• Ikonisys Inc.
• Miltenyi Biotec
• IVDiagnostics
• BioFluidica
• Canopus Bioscience Ltd.
• Biolidics Limited
• Creativ MicroTech, Inc.
• LungLife AI, Inc.
• Epic Sciences
• Rarecells Diagnostics
• ScreenCell
• Menarini Silicon Biosystems
• LineaRx, Inc. (Vitatex, Inc.)
• Sysmex Corporation
• STEMCELL Technologies, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Regenerative Medicine Market to Observe Strong Development by 2030|Top Industry Players Integra LifeSciences Corporation

 

Regenerative Medicine Market Growth & Trends

The global regenerative medicine market size is expected to reach USD 90.01 billion by 2030, expanding at a CAGR of 16.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. The presence of a strong pipeline is one of the major drivers in the regenerative medicine market. Companies invest heavily in R&D to upgrade their products with the latest technology and fulfil the unmet needs of their customers.

Furthermore, with the increasing demand for disease treatment therapies, companies have focused their efforts to accelerate R&D for gene therapies that target the cause of disease at a genomic level. The cell and gene therapies in the U.S. pipeline programs (Phase I-III trials) grew from 289 in 2018 to 362 by 2019 according to the data published by PhRMA. This represents an increase of 25% in a single year. Continuous advancements in this field would further boost the demand for regenerative medicines.

Technological advancements such as stem cells, tissue engineering, and nanotechnology has made regenerative medicines a highly interdisciplinary in field. Stem cells are undifferentiated cells, which have the capability to repair and/or regenerate into other cells such as cartilage, tendons, ligaments, muscle, and bones. In July 2021, BlueRock Therapeutics received FDA approval for its pluripotent stem cell-derived dopaminergic neuron therapy, DA01, for advanced Parkinson’s disease treatment. This approval was expected to expand the company’s offerings.

Several key players are taking strategic initiatives such as new product development, strategic alliances, and others have contributed to the regenerative medicine market growth. For instance, in November 2021, Astellas Pharma, Inc. entered into an agreement with Pantherna Therapeutics GmbH to study mRNA-based regenerative medicine. Under this initiative, Astellas' high drug discovery capabilities and Pantherna's state-of-the-art mRNA platform will be used to promote research on developing a new program. In addition, in May 2021, Bayer AG entered into a collaboration with Senti Bio for gene circuit-engineered cell therapies development for regenerative medicine.

Request a free sample copy or view report summary: Regenerative Medicine Market Report

Regenerative Medicine Market Report Highlights

• The therapeutics segment held the largest share in the regenerative medicine market, owing to the growing aging population coupled with an increasing rate of age-related disorders.
• The rise in a number of clinical trials for stem cell and tissue-based regenerative therapies along with an increase in demand for regenerative therapies is expected to positively influence the growth of the market.
• Stem cell and progenitor cell-based therapies are projected to witness significant growth owing to huge investments in the R&D space and a growing number of stem cell banks
• North America dominated the market in 2023 owing to the presence of a significant number of research organizations and universities which are working on R&D of stem cell-based therapies.
• Asia Pacific is anticipated to witness the fastest growth in the coming years owing to the rapid adoption of cell-based methods in the healthcare industry.
• By therapeutic category, the oncology segment dominated the segment in 2023 owing to the increasing cases of cancer globally which is rising the demand for better solutions. The growing number of robust pipelines is driving the market growth.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-regenerative-medicine-market

Regenerative Medicine Market Segmentation

Grand View Research has segmented the global regenerative medicine market based on product, therapeutic category, and region:

Regenerative Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

• Therapeutics
  • Primary Cell-based Therapeutics
    • Dermatology
    • Musculoskeletal
    • Surgical
    • Dental
    • Others
  • Stem Cell & Progenitor Cell-based Therapeutics
    • Autologous
    • Allogenic
    • Others
  • Cell-based Immunotherapies
  • Gene Therapies
• Tools
• Banks
• Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2018 - 2030)

• Dermatology
• Musculoskeletal
• Immunology & Inflammation
• Oncology
• Cardiovascular
• Ophthalmology
• Others           

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Regenerative Medicine Market

• AstraZeneca plc
• Hoffmann-La Roche Ltd.
• Integra Lifesciences Corp.
• Astellas Pharma, Inc.
• Cook Biotech, Inc.
• Bayer AG
• Pfizer, Inc.
• Merck KGaA
• Abbott
• Vericel Corp.
• Novartis AG
• GlaxoSmithKline (GSK)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Durable Medical Equipment Market is Estimated To Reach A Valuation of $331.14 Billion by 2030: Grand View Research Inc.

 Durable Medical Equipment Market Growth & Trends

The global durable medical equipment market size was valued at USD 331.14 billion in 2030 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by a rise in chronic diseases, such as kidney failure and cancer. Moreover, technological advancements along with a strong reimbursement scenario are likely to boost the durable medical equipment (DME) market over the forecast period.

The growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and a lack of skilled professionals may limit the market growth.

The COVID-19 pandemic has initially affected the market due to the shortage of supply of the product. The market players have resulted in a decline in operations, sales, and revenue during the pandemic. The outbreak has temporarily changed the customer’s spending habits due to the restrictions imposed by the government. The pandemic has resulted in rising costs of the product and post-sale services for the recovery of financial loss incurred by the market players.

The availability of technologically advanced products has also played an important role in positively impacting the growth of the market. Countries such as U.S., UK, and Germany are innovators and early adopters of advanced technologies, thus these are the most important customers for medical device markets with rapid technological innovations. Technological breakthroughs concentrating on increasing efficiency are expected to occur during the forecast period, thereby driving market growth.

Request a free sample copy or view the report summary: Durable Medical Equipment Market Report

Durable Medical Equipment Market Report Highlights

• Monitoring and therapeutic devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability.
• Home healthcare is anticipated to be the fastest-growing segment in the forecast period as it is less expensive and preferred by aged people.
• North America led the market with the largest share in 2022 and will witness steady growth in the future on account of the presence of major companies in the region.
• Asia Pacific is expected to register the highest CAGR in the forecast period owing to the presence of a large target population base and improving healthcare facilities.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-durable-medical-equipment-dme-market

Durable Medical Equipment Market Segmentation

Grand View Research has segmented the durable medical equipment (DME) market report based on product, end use, and region:

Durable Medical Equipment Product Outlook (Revenue, USD Million; 2018 - 2030)

• Personal Mobility Devices
  • Wheelchairs
  • Scooters
  • Walker and Rollators
  • Cranes and Crutches
  • Door Openers
  • Other Devices
• Bathroom Safety Devices and Medical Furniture
  • Commodes and Toilets
  • Mattress & Bedding Devices
• Monitoring and Therapeutic Devices
  • Blood Sugar Monitors
  • Continuous Passive Motion (CPM)
  • Infusion Pumps Market
  • Nebulizers
  • Oxygen Equipment
  • Continuous Positive Airway Pressure (CPAP)
  • Suction Pumps
  • Traction Equipment
  • Others Equipment

Durable Medical Equipment End Use Outlook (Revenue, USD Million; 2018 - 2030)

• Hospitals
• Nursing Homes
• Home Healthcare
• Other End-user

Durable Medical Equipment Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Durable Medical Equipment Market

• Invacare Corporation
• ArjoHuntleigh
• Stryker Corporation
• Hill Rom, Inc.
• Drive Medical
• GF Health Products, Inc.
• Sunrise Medical
• Medline Industries
• Hill Rom, Inc.
• Carex Health Brands, Inc
• Becton, Dickinson and Company
• General Electric Company
• Medtronic PLC
• Compass Health Brands
• Getinge AB
• Resmed Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Stem Cells Market is Poised to Exhibit A Moderate 9.74% CAGR through 2030

 

Stem Cells Market Growth & Trends

The global stem cells market size is expected to reach USD 31.6 billion by 2030, registering a CAGR of 9.74% from 2023 to 2030, according to a new report by Grand View Research, Inc. Stem cells are cells that can differentiate into a variety of other cells, eventually forming organs or tissues. Many studies have been conducted over the years to assess the true potential of stem cells, leading to a variety of applications in the fields of genetic disease treatment, neurological disorders, oncology, and organ regeneration. The market is driven by the rising number of banks, growing focus on increasing therapeutic potential of these products, and extensive research for the development of regenerative medicines, among other factors.

The growing focus on regenerative therapies is fueling market expansion. iPSCs are becoming increasingly popular for the creation of customized cellular therapies, and opening up new possibilities in regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can aid in the treatment of placenta issues during pregnancy. The researchers devised a new method for producing induced trophoblast stem cells that can be used to generate placenta cells. The research will aid in the development of an in-vitro human placenta model and pave the way for future therapies.

Moreover, COVID-19 is acting as a catalyst for promoting the market growth. Several countries such as U.S., China, and Iran, have started conducting clinical trials using cellular therapies for treatment of COVID-19 infections. Furthermore, the use of cell therapy in the treatment of COVID-19 patients has yielded excellent results, which is fueling market expansion. In January 2020, a group of researchers in Beijing, China, tested stem cell treatment on patients to see if it was beneficial against COVID-19. The study found that administering intravenous clinical-grade MSCs to COVID-19 patients during first trial of treatment, improved their functional results and promoted enhanced recovery. 

Increasing prevalence of cancer is one of the key factors contributing to the growth over the forecast period. Failure of combination therapy and chemotherapy for treatment of cancer has led to the shift in preference of physicians from such therapies to autologous and allogeneic stem cell therapy, thereby boosting the growth. Moreover, key market players and the government bodies are continuously investing in cancer research. For instance, in November 2021, California Institute for Regenerative Medicine invested USD 4 million in therapy targeting patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) 

Introduction of novel technologies for the usage and adoption of cell based therapy is expected to boost the growth over the forecast period. Automation in adult stem cell & cord blood processing and storage are the key technologies expected to positively influence the market growth. For instance, various scientists are aiming for the approval of safe, and successful treatments using stem cells in a broad range of diseases. In 2021, companies such as Biotech Cellino invested USD 75 million in an effort to merge Artificial Intelligence technology for the development of automated stem cell manufacturing, that has the ability to regularizing access to cell treatments while aiming to be cost effective. 

On the other hand, high cost of therapy is expected to hinder the market growth. For example, Bio informant, a stem cell research firm, reported that the cost of stem cell therapy ranges between USD 5,000 and USD 8,000 per patient, with some cases costing as much as USD 25,000 or more depending on the complexity of the procedure. Furthermore, restrictions on stem cell research activities have traditionally hampered embryonic stem cell growth, resulting in a meager share of the total market despite its advantages. 

Request a free sample copy or view report summary: Stem Cells Market Report

Stem Cells Market Report Highlights

• ASCs segment accounted for the largest share in 2022 as it is considered as a gold standard in stem cell-based therapies. They are widely accepted owing to their consistent clinical success especially in hematopoietic transplants and there is a relatively less controversial view regarding their origin
• The iPSC segment is expected to witness a lucrative CAGR through 2023-2030 owing to the increasing focus of companies in using iPS for cell therapies. For instance, in July 2020, Cynata Therapeutics Limited announced positive results for the phase 1 clinical trial of CYP-001, the company’s lead iPSC derived Cymerus
• Regenerative medicine dominated the market in 2022 owing to increasing funding by the government for the development of regenerative medicines. For instance, in October 2020, the AusBiotech-led consortium received funding of USD 300,000 from MTPConnect’s Industry Growth Centre Project Fund for the development of regenerative medicines in Australia
• Cell acquisition technology held the largest market share in 2022 and is expected to expand at the fastest CAGR through 2023-2030 owing to increasing research studies involving cell harvesting
• Allogenic therapy dominated the market in 2022 owing to the increasing application of allogeneic stem cell transplants for cancer treatment
• Pharmaceutical and biotechnology companies held the largest market share in 2022, and is anticipated to exhibit at fastest CAGR owing to upsurge in R&D, increasing clinical trials coupled with strategic activities by major market players
• North America market encompasses U.S. and Canada. The factors contributing to the market growth in the region include robust government funding, increasing research, and the presence of prominent players in this region
• Asia Pacific is expected to grow with the fastest CAGR of through 2023 to 2030 owing to increasing expansion by key companies in this region. For instance, in April 2020, Seneca Biopharma completed its new stem cell manufacturing facility in Suzhou, China 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-stem-cells-market

Stem Cells Market Segmentation 

Grand View Research has segmented the global stem cells market based on product, technology, application, therapy, end-user, and region:

Stem Cells Product Outlook (Revenue, USD Million, 2018 - 2030)

• Adult Stem Cells (ASCs)
  • Hematopoietic
  • Mesenchymal
  • Neural
  • Epithelial/Skin
  • Others
• Human Embryonic Stem Cells (HESCs)
• Induced Pluripotent Stem Cells (iPSCs)
• Very Small Embryonic Like Stem Cells

Stem Cells Application Outlook (Revenue, USD Million, 2018 - 2030)

• Regenerative Medicine
  • Neurology
  • Orthopedics
  • Oncology
  • Hematology
  • Cardiovascular and Myocardial Infraction
  • Injuries
  • Diabetes
  • Liver Disorder
  • Incontinence
  • Others
• Drug Discovery & Development

Stem Cells Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Cell Acquisition
  • Bone Marrow Harvest
  • Umbilical Blood Cord
  • Apheresis
• Cell Production
  • Therapeutic Cloning
  • In-vitro Fertilization
  • Cell Culture
  • Isolation
• Cryopreservation
• Expansion And Sub-Culture

Stem Cells Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Autologous
• Allogenic

Stem Cells End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Hospitals & Cell Banks
• Academic & Research Institutes

Stem Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Stem Cells Market

• Advanced Cell Technology Inc.
• STEMCELL Technologies Inc.
• Cellular Engineering Technologies Inc.
• CellGenix GmbH       
• PromoCell GmbH
• Kite Pharma   
• Lonza 
• Cellartis AB
• Angel Biotechnology
• Brainstorm Cell Therapeutics
• Celgene Corporation
• Osiris Therapeutics
• Genea Biocells
• Bioheart Inc.
• Waisman Biomanufacturing
• Tigenix
• Caladrius Biosciences
• Gamida Cell

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Astaxanthin Market Latest Innovations, Drivers and Industry Key Events 2024 – 2030: Grand View Research Inc.

 Astaxanthin Market Growth & Trends

The global astaxanthin market size is expected to reach USD 7.28 billion by 2030, set to grow at a 17.1% CAGR from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for nutraceuticals and growing applications of carotenoids in the animal feed industry & aquaculture are the major factors driving the market growth. Moreover, the rapidly aging population and the growing health awareness among consumers are likely to support market expansion.

The market is anticipated to witness growth opportunities owing to growth in the aquaculture and fishing sectors. For instance, Germany is expanding its fish production and according to the federal statistical office of Germany, the country produced around 18,300 tons of fish in 2021. The growth in the aquaculture sector across the globe is likely to propel the demand for astaxanthin as the pigment helps to boost the immunity of animals and enhance the pigmentation of aquatic animals, such as ornamental fish, and rainbow trout.

Moreover, the market growth is also fueled by various research & development activities to increase the adoption of astaxanthin. For instance, in December 2021, AstaReal and the University of Tsukuba announced a new patent and research showing that the astaxanthin molecules modulate the genes of the brain involved in neuron formation, memory, and learning. Moreover, in July 2020, Russian and German university scientists from SPbPU and TUHH announced a collaboration to enhance the production of astaxanthin for its antioxidant application.

Moreover, increasing studies related to the health benefits of natural astaxanthin are expected to increase the market uptake. For instance, in August 2022, a study published by the American Journal of Clinical Nutrition stated that krill oil can help manage stiffness, knee pain, and physical function in adults with osteoarthritis & knee pain between the ages of 40 and 65 years.

In addition, owing to the high demand for astaxanthin in international markets various leading players are strengthening their supply chain capabilities to make their products available. For instance, in July 2021, Atacama Bio Natural Products S.A. signed an exclusive distribution agreement with Guangzhou Carelife Food Additives Co., Ltd. to promote its distribution network in China. Moreover, in June 2022, Pharmactive Biotech Products partnership with Singapore-based Nutraconnect to introduce scientifically backed novel nutraceuticals into the Asia Pacific market.

Furthermore, supportive regulatory policies and increasing approval of products are driving the industry’s growth. For instance, in July 2021, NextFern Technologies received regulatory approval for its Astafern from Health Canada. Astafern is an innovative fermented astaxanthin antioxidant in form of gummies. In addition, the government has undertaken supportive registration requirements for carotenoid-based coloring agents and mixed feeds containing carotenoid-based coloring agents.

Request a free sample copy or view report summary: Astaxanthin Market Report

Astaxanthin Market Report Highlights

• Based on product, the dried algae meal or biomass segment accounted for the largest share in 2023 due to the high usage as animal feed and lower cost of production
• The aquaculture & animal feed segment was the highest revenue contributor in 2023. Whereas, the nutraceuticals segment is expected to exhibit the fastest CAGR during the projected period
• The Asia Pacific region is expected to grow at the fastest rate over the forecast period due to the rising investments by market players and increasing research activities in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/astaxanthin-market

Astaxanthin Market Segmentation

Grand View Research has segmented the global astaxanthin market on the basis of source, product, application, and region

Astaxanthin Source Outlook (Revenue, USD Million, 2018 - 2030) (Volumein Metric Tonnes)

• Natural
  • Yeast
  • Krill/Shrimp
  • Microalgae
  • Others
• Synthetic

Astaxanthin Product Outlook (Revenue, USD Million, 2018 - 2030)

• Dried Algae Meal or Biomass
• Oil
• Softgel
• Liquid
• Others

Astaxanthin Application Outlook (Revenue, USD Million, 2018 - 2030)

• Nutraceuticals
• Cosmetics
• Aquaculture And Animal Feed
• Food
  • Functional Foods And Beverages
  • Other Traditional Food Manufacturing Applications
• Others

Astaxanthin Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Ecuador
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Kuwait

List of Key Players of Astaxanthin Market

• Algatech Ltd
• MicroA
• Cyanotech Corporation
• Algalíf Iceland ehf
• Beijing Gingko Group (BGG)
• PIVEG, Inc.
• Fuji Chemical Industries Co., Ltd
• ENEOS Corporation
• Atacama Bio Natural Products S.A.
• I.D. – Parry (India) Limited (Alimtec S.A., Valensa International)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Dental Implants Market to Witness Soaring Growth During 2023 – 2030: Grand View Research Inc.

 Dental Implants Market Growth & Trends

The global dental implant market size is expected to reach USD 9.62 billion by 2030, registering a CAGR of 9.8% according to a new report by Grand View Research, Inc. Rising demand for tooth replacement has provided good growth potential to the market. The increasing number of dental injuries owing to road accidents and sports injuries are some of the major factors boosting the market growth.

With growing aesthetic awareness, people are exploring more treatment options, which is leading to the growth of the market. For instance, as per the American Academy of Cosmetic Dentistry data, more than 95.0% of individuals across the globe believe that their smile is a vital social asset and nearly 84.0% revealed to be under increased pressure to perfect their smile, thus increasing the product demand. Dental implants are considered the only restorative technique that preserves and stimulates natural bone. Owing to the growing number of edentulous people, the demand for prosthetics is increasing, which is expected to be one of the major impact-rendering drivers for the market.

Several industries have halted their services due to the COVID-19 pandemic. However, the dental care industry is greatly impacted by the significant decrease in elective procedures, many of which are being postponed or canceled so that hospitals can focus their resources on treating patients with COVID-19. Major Countries like the U.S and India procure raw materials and electronic components from China, which has disrupted the supply chain of many dental equipments and product manufacturers. However, with the decrease in the number of COVID-19 cases, hospitals are likely to begin scheduling elective procedures, depending on their capacity of admission and patients comfort level.

Request a free sample copy or view report summary: Dental Implant Market Report

Dental Implants Market Report Highlights

• The titanium implant type segment held the largest market share in 2020 due to its wide applications, durability, and cost-effectiveness
• Zirconia implants are anticipated to witness a lucrative growth rate over the forecast period due to better flexural strength, improved aesthetic appearance, and less corrosiveness as compared to titanium
• North America dominated the market in 2020 owing to high awareness about restorative treatments and the presence of established market players

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dental-implants-market

Dental Implants Market Segmentation

Grand View Research has segmented the dental implants market on the basis of implant type and region:

Dental Implants Implant Type Outlook (Revenue, USD Million, 2018 - 2030)

• Titanium Implants
• Zirconia Implants

Dental Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Austria
  • The Netherlands
  • Poland
  • Romania
  • Czech Republic
  • Greece
  • Sweden
  • Portugal
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Dental Implants Market

• BioHorizons IPH, Inc.
• Nobel Biocare Services AG
• Zimmer Biomet Holdings, Inc.
• OSSTEM IMPLANT
• Institut Straumann AG
• Bicon, LLC
• Leader Italy
• Anthogyr SAS
• DENTIS
• DENTSPLY Sirona
• DENTIUM Co., Ltd.
• T-Plus Implant Tech. Co.
• KYOCERA Medical Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.